Advertisement
Screener

Monte Rosa Therapeutics, Inc. (GLUE) Stock Issued During Period, Value, New Issues

2.3 / 5 stars · 12/26 Roast Me

Monte Rosa Therapeutics, Inc. Stock Issued During Period, Value, New Issues

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • Monte Rosa Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $323.81M.
  • Monte Rosa Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $30.93M.
  • Monte Rosa Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2021-06-30 was $203.88M.
  • Monte Rosa Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2025 was $23.89M.
  • Monte Rosa Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2021 was $234.65M.
Period endStock Issued During Period, Value, New Issues 3 monthStock Issued During Period, Value, New Issues 12 month
2026-03-31$323.81M
10-Q · filed 2026-08-06
2025-12-31$23.89M
10-K · filed 2026-03-17
2021-12-31$234.65M
10-K · filed 2023-03-16
2021-09-30$30.93M
10-Q · filed 2022-11-10
2021-06-30$203.88M
10-Q · filed 2022-11-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cullinan Therapeutics, Inc. (CGEM)United States$0.993B-5.72
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
MeiraGTx Holdings plc (MGTX)United States$1.061B16.10
Vor Biopharma Inc. (VOR)United States$1.091B1.60
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Candel Therapeutics, Inc. (CADL)United States$0.885B-8.86
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Replimune Group, Inc. (REPL)United States$1.186B-3.13
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
4D Molecular Therapeutics, Inc. (FDMT)United States$0.733B-4.10